Aucun résultat
Professor Brett D. Thombs has authored more than 400 peer-reviewed articles. He is the principal investigator or a co-investigator on numerous grants from the Canadian Institutes of Health Research (CIHR) and the Fonds de la recherche Québec – santé (FRQ-S), the US National Institutes of Health (NIH), and private organizations, including the Arthritis Society, Scleroderma Canada, and provincial scleroderma patient organizations.
Awards that Pr. Thombs or teams he has led have received in recognition of the team’s work include the Cochrane Collaboration’s Bill Silverman Prize, the Academy of Psychosomatic Medicine’s Research Award, the Association of Rheumatology Health Professional’s Distinguished Scholar Award, Researcher Salary Awards (Junior I, Junior II, Senior) from the FRQ-S, an Arthritis Society Salary Award, the Jewish General Hospital Award for Excellence in Clinical Research, the Canadian Psychological Association Health Psychology Section Early Career Award, the Canadian Psychological Association’s President’s New Researcher Award, an American College of Rheumatology Research and Education Foundation Health Professional Investigator Award, and a CIHR New Investigator Award.
Pr. Thombs was the lead author of an international team that published an article on depression screening in cardiovascular care settings, which was a finalist for the 2009 BMJ Group Research Paper of the Year Award. In 2014, he was one of two recipients of the inaugural version of the McGill Principal’s Prize for Outstanding Emerging Researchers, which is awarded to McGill’s top investigators within 10 years of their highest degree from any of its 13 faculties and schools. Pr. Thombs is a Fellow of the Canadian Academy of Health Sciences and a Member of the College of the Royal Society of Canada.
Professor Brett D. Thombs is internationally known for:
Pr. Thombs is Director of the Scleroderma Patient-centered Intervention Network (SPIN) and Director of the DEPRESsion Screening Data (DEPRESSD) Project. During COVID-19, his team has conducted the most comprehensive evidence synthesis on mental health changes during the pandemic.
Sun Y, Wu Y, Fan S, Dal Santo T, Li L, Jiang X, Li K, Wang Y, Tasleem A, Krishnan A, He C, Bonardi O, Boruff JT, Rice DB, Markham S, Levis B, Azar M, Thombs-Vite I, Neupane D, Agic B, Fahim C, Martin MS, Sockalingam S, Turecki G, Benedetti A, Thombs BD. BMJ. 2023;380:e074224. doi:10.1136/bmj-2022-074224. PMID: 36889797.
Thombs BD, Kwakkenbos L, Levis B, Bourgeault A, Henry RS, Levis AW, Harb S, Tao L, Carrier ME, Bustamente L, Duchek D, Dyas L, El-Baalbaki G, Ellis K, Rice DB, Wurz A, Nordlund J, Gagarine M, Turner KA, Østbø N, Culos-Reed N, Hebblethwaite S, Patten S, Bartlett SJ, Varga J, Mouthon L, Markham S, Martin MS, Benedetti A, and the SPIN-CHAT Patient Advisory Team and Program Facilitators on behalf of the Scleroderma Patient-centered Intervention Network Investigators. Lancet Rheumatol. 2021;3:e427-e437. doi:10.1016/S2665-9913(21)00060-6. PMID: 33899008.
Negeri ZF, Levis B, Sun Y, He C, Krishnan A, Wu Y, Bhandari PM, Neupane D, Brehaut E, Benedetti A, Thombs BD, DEPRESSD PHQ Group. BMJ. 2021;375:n2183. doi:10.1136/bmj.n2183. PMID: 34610915.
Levis B, Sun Y, He C, Wu Y, Krishnan A, Bhandari PM, Neupane D, Imran M, Brehaut E, Negeri Z, Fischer FH, Benedetti A, Thombs BD, Depression Screening Data (DEPRESSD) PHQ Collaboration. JAMA. 2020;323(22):2290-2300. doi:10.1001/jama.2020.6504. PMID: 32515813.
Wu Y, Levis B, Sun Y, Krishnan A, Neupane D, Bhandari PM, Negeri Z, Benedetti A, Thombs BD, DEPRESSD HADS Group. BMJ. 2021;373:n972. doi:10.1136/bmj.n972. PMID: 33972268.
You have the power to make a difference! Your gift will support vital research at the Lady Davis Institute for Medical Research (LDI) that will translate into disease prevention, improved diagnoses, earlier detection, new and enhanced therapies, a better quality of life, wellness and hope for all of us.
Faire la différence, vous avez ce don! Votre contribution soutiendra la recherche essentielle menée à l’Institut Lady Davis qui permettra la prévention des maladies, des diagnostics plus précis, des dépistages plus rapides, des traitements innovants et plus performants, une meilleure qualité de vie, le bien-être et l’espoir pour nous tous.
Copyright © 2024 | Lady Davis Institute for Medical Research/Jewish General Hospital
Conception et développement : Yankee Media